{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:02:47Z","timestamp":1792008167954,"version":"4.4.0"},"reference-count":87,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2023J01410"],"award-info":[{"award-number":["2023J01410"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Polymers"],"abstract":"<jats:p>Inflammatory bowel disease (IBD), including Crohn\u2019s disease and ulcerative colitis, is a chronic inflammatory disorder of the gastrointestinal tract that imposes an increasing global health burden. Conventional pharmacological treatments are often limited by systemic side effects and insufficient drug accumulation at inflamed intestinal sites. Enzyme-responsive polymeric drug delivery systems have emerged as a promising strategy to overcome these limitations by enabling site-specific and controlled drug release within the pathological microenvironment of the colon. This review summarizes recent advances in enzyme-responsive polymeric platforms designed for IBD therapy. We first discuss the altered enzymatic landscape in the intestinal microenvironment of IBD, including host-derived inflammatory enzymes such as esterases, matrix metalloproteinases, and hyaluronidase, as well as microbiota-derived enzymes such as azoreductase, cellulase, and amylase. These enzymes provide intrinsic biological triggers for selective polymer degradation and drug release. We then categorize enzyme-responsive polymeric delivery systems according to the enzymes involved and highlight representative material design strategies, including polymer prodrugs, core\u2013shell nanocarriers, enzyme-degradable hydrogels, and polysaccharide-based carriers. Particular emphasis is placed on the multifunctional roles of polymers that enable targeted delivery, mucosal adhesion, and therapeutic synergy through bioactive degradation products. Finally, current challenges and future directions toward multi-stimuli-responsive systems and clinically translatable polymeric nanomedicine for precision IBD therapy are discussed.<\/jats:p>","DOI":"10.3390\/polym18101146","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T09:03:37Z","timestamp":1778144617000},"page":"1146","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Enzyme-Responsive Polymeric Drug Delivery Systems for the Treatment of Inflammatory Bowel Diseases: A Review"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4772-3735","authenticated-orcid":false,"given":"Junru","family":"Li","sequence":"first","affiliation":[{"name":"College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanran","family":"Yu","sequence":"additional","affiliation":[{"name":"College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3621-5233","authenticated-orcid":false,"given":"Da","family":"Huang","sequence":"additional","affiliation":[{"name":"College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrg3182","article-title":"The human microbiome: At the interface of health and disease","volume":"13","author":"Cho","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Sahoo, D.K., Heilmann, R.M., Paital, B., Patel, A., Yadav, V.K., Wong, D., and Jergens, A.E. (2023). Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1217165"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41572-020-0156-2","article-title":"Crohn\u2019s disease","volume":"6","author":"Roda","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/ecco-jcc\/jjz139","article-title":"Viewpoint: Inflammatory Bowel Diseases Among Immigrants From Low- to High-Incidence Countries: Opportunities and Considerations","volume":"14","author":"Agrawal","year":"2020","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2024-334395","article-title":"British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025","volume":"74","author":"Moran","year":"2025","journal-title":"Gut"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Yeshi, K., Jamtsho, T., and Wangchuk, P. (2024). Current Treatments, Emerging Therapeutics, and Natural Remedies for Inflammatory Bowel Disease. Molecules, 29.","DOI":"10.3390\/molecules29163954"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e1988","DOI":"10.1002\/wnan.1988","article-title":"Polymer-drug and polymer-protein conjugated nanocarriers: Design, drug delivery, imaging, therapy, and clinical applications","volume":"16","author":"Guo","year":"2024","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.crohns.2014.02.024","article-title":"Nanotechnology in the treatment of inflammatory bowel diseases","volume":"8","author":"Viscido","year":"2014","journal-title":"J. Crohns Colitis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2544689","DOI":"10.1080\/10717544.2025.2544689","article-title":"Advances in oral treatment of inflammatory bowel disease using protein-based nanoparticle drug delivery systems","volume":"32","author":"Lin","year":"2025","journal-title":"Drug Deliv."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1136\/gutjnl-2024-334346","article-title":"DUOX2 activation drives bacterial translocation and subclinical inflammation in IBD-associated dysbiosis","volume":"74","author":"Hazime","year":"2025","journal-title":"Gut"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.actbio.2024.09.007","article-title":"Stimulus-responsive drug delivery nanoplatforms for inflammatory bowel disease therapy","volume":"188","author":"Long","year":"2024","journal-title":"Acta Biomater."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2022.02.028","article-title":"Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment","volume":"345","author":"Wang","year":"2022","journal-title":"J. Control Release"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"202401408","DOI":"10.1002\/smtd.202401408","article-title":"Colon Enzyme-Activated Prebiotic Nanomedicine for Targeted Therapy of Inflammatory Bowel Disease","volume":"10","author":"Cao","year":"2026","journal-title":"Small Methods"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.addr.2020.07.010","article-title":"Advanced nanomedicines for the treatment of inflammatory diseases","volume":"157","author":"Brusini","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2022.12.044","article-title":"Harnessing polymer-derived drug delivery systems for combating inflammatory bowel disease","volume":"354","author":"Pu","year":"2023","journal-title":"J. Control. Release"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2147\/DDDT.S461977","article-title":"Nanoparticle-Based Drug Delivery Systems for Inflammatory Bowel Disease Treatment","volume":"18","author":"Gao","year":"2024","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1039\/D3TB02302H","article-title":"Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: Latest advances","volume":"12","author":"Hu","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cell.2024.12.016","article-title":"Metagenome-informed metaproteomics of the human gut microbiome, host, and dietary exposome uncovers signatures of health and inflammatory bowel disease","volume":"188","author":"Leshem","year":"2025","journal-title":"Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41564-025-02197-z","article-title":"Gut microbiome-mediated transformation of dietary phytonutrients is associated with health outcomes","volume":"11","author":"Zhang","year":"2025","journal-title":"Nat. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Su, M., Tang, T., Tang, W., Long, Y., Wang, L., and Liu, M. (2023). Astragalus improves intestinal barrier function and immunity by acting on intestinal microbiota to treat T2DM: A research review. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1243834"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2203963","DOI":"10.1080\/19490976.2023.2203963","article-title":"Diverse but desolate landscape of gut microbial azoreductases: A rationale for idiopathic IBD drug response","volume":"15","author":"Simpson","year":"2023","journal-title":"Gut Microbes"},{"key":"ref_24","first-page":"100362","article-title":"Pectinase responsive nanoplatform for oral targeted delivery 5-aminosalicylic acid and zinc coordination driven nanozyme in inflammatory bowel disease treatment","volume":"10","author":"Lin","year":"2025","journal-title":"Int. J. Pharm. X"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.matbio.2023.06.007","article-title":"TSG6 hyaluronan matrix remodeling dampens the inflammatory response during colitis","volume":"121","author":"Albtoush","year":"2023","journal-title":"Matrix Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s12951-024-02749-1","article-title":"Oral enzyme-responsive nanoprobes for targeted theranostics of inflammatory bowel disease","volume":"22","author":"Cao","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"53168","DOI":"10.1021\/acsami.5c11808","article-title":"Leukocyte Esterase-Activated Nanoconjugates Enables Precise Local Therapy of Ulcerative Colitis via Inflamed Tissue-Selective Drug Delivery","volume":"17","author":"Lee","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"102166","DOI":"10.1016\/j.molmet.2025.102166","article-title":"Functional regulation of macrophages by Ces1d-mediated lipid signaling in immunometabolism","volume":"97","author":"Shao","year":"2025","journal-title":"Mol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"122586","DOI":"10.1016\/j.biomaterials.2024.122586","article-title":"Co-delivery of Plinabulin and Tirapazamine boosts anti-tumor efficacy by simultaneously destroying tumor blood vessels and killing tumor cells","volume":"309","author":"Lv","year":"2024","journal-title":"Biomaterials"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"27839","DOI":"10.1021\/acsami.5c02190","article-title":"Beta-Sitosterol-Conjugated Sinapic Acid-Engineered Nanoliposome: Biomucoadhesive and Enzyme-Responsive Targeted Oral Therapy in Ulcerative Colitis","volume":"17","author":"Kanika","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12951-023-01889-0","article-title":"Surface-anchored microbial enzyme-responsive solid lipid nanoparticles enabling colonic budesonide release for ulcerative colitis treatment","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1080\/10717544.2021.1934189","article-title":"An efficient enzyme-triggered controlled release system for colon-targeted oral delivery to combat dextran sodium sulfate (DSS)-induced colitis in mice","volume":"28","author":"Li","year":"2021","journal-title":"Drug Deliv."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Sheng, W., Ji, G., and Zhang, L. (2023). Immunomodulatory effects of inulin and its intestinal metabolites. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1224092"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/20014091091841","article-title":"Inulin and Oligofructose as Dietary Fiber: A Review of the Evidence","volume":"41","author":"Flamm","year":"2001","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s43162-024-00366-w","article-title":"The role of fecal matrix metalloprotease-9 as a non-invasive marker in diagnosis and assessment of clinical activity in inflammatory bowel disease patients","volume":"36","author":"Mohamed","year":"2024","journal-title":"Egypt. J. Intern. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1515\/jomb-2017-0013","article-title":"Is Oxidative Stress Associated with Activation and Pathogenesis of Inflammatory Bowel Disease?","volume":"36","author":"Yuksel","year":"2017","journal-title":"J. Med. Biochem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1023\/A:1011033121528","article-title":"Colonic Drug Delivery: Prodrug Approach","volume":"18","author":"Sinha","year":"2001","journal-title":"Pharm. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.34133\/bmr.0062","article-title":"Combining Gut Microbiota Modulation and Enzymatic-Triggered Colonic Delivery by Prebiotic Nanoparticles Improves Mouse Colitis Therapy","volume":"28","author":"Li","year":"2024","journal-title":"Biomater. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"114240","DOI":"10.1016\/j.jconrel.2025.114240","article-title":"Oral multifunctional gel beads for the targeted treatment of inflammatory bowel disease","volume":"387","author":"Hu","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"115613","DOI":"10.1016\/j.carbpol.2019.115613","article-title":"Chitosan-modified lipid nanodrug delivery system for the targeted and responsive treatment of ulcerative colitis","volume":"230","author":"Chen","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"213735","DOI":"10.1016\/j.bioadv.2023.213735","article-title":"Dual stimuli-responsive delivery system for self-regulated colon-targeted delivery of poorly water-soluble drugs","volume":"157","author":"Rabeh","year":"2024","journal-title":"Biomater. Adv."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.colsurfb.2014.09.026","article-title":"Enzyme\/pH dual sensitive polymeric nanoparticles for targeted drug delivery to the inflamed colon","volume":"123","author":"Naeem","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1016\/j.cclet.2022.03.110","article-title":"Oral colon-targeted mucoadhesive micelles with enzyme-responsive controlled release of curcumin for ulcerative colitis therapy","volume":"33","author":"Zhang","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.carbpol.2016.01.026","article-title":"Self assembled hyaluronic acid nanoparticles as a potential carrier for targeting the inflamed intestinal mucosa","volume":"144","author":"Vafaei","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"117998","DOI":"10.1016\/j.carbpol.2021.117998","article-title":"Calcium pectinate and hyaluronic acid modified lactoferrin nanoparticles loaded rhein with dual-targeting for ulcerative colitis treatment","volume":"263","author":"Luo","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41563-019-0462-9","article-title":"Hyaluronic acid\u2013bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis","volume":"19","author":"Lee","year":"2020","journal-title":"Nat. Mater."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"47056","DOI":"10.1039\/C4RA09640A","article-title":"pH- and electro-response characteristics of bacterial cellulose nanofiber\/sodium alginate hybrid hydrogels for dual controlled drug delivery","volume":"4","author":"Shi","year":"2014","journal-title":"RSC Adv."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"122647","DOI":"10.1016\/j.carbpol.2024.122647","article-title":"Nanofiber-boosted retrograded starch\/pectin microparticles for targeted 5-Aminosalicylic acid delivery in inflammatory bowel disease: In vitro and in vivo non-toxicity evaluation","volume":"346","author":"Meneguin","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"121884","DOI":"10.1016\/j.ijpharm.2022.121884","article-title":"Colon-targeted oral nanoparticles based on ROS-scavenging hydroxyethyl starch-curcumin conjugates for efficient inflammatory bowel disease therapy","volume":"623","author":"Xu","year":"2022","journal-title":"Int. J. Pharm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s12951-024-02725-9","article-title":"Enzyme\/ROS dual-sensitive nanoplatform with on-demand Celastrol release capacity for enhanced ulcerative colitis therapy by ROS scavenging, microbiota rebalancing, inflammation alleviating","volume":"22","author":"Shi","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.carbpol.2018.03.025","article-title":"Starch film-coated microparticles for oral colon-specific drug delivery","volume":"191","author":"Chen","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"131107","DOI":"10.1016\/j.ijbiomac.2024.131107","article-title":"Colon-targeted hydroxyethyl starch-curcumin microspheres with high loading capacity ameliorate ulcerative colitis via alleviating oxidative stress, regulating inflammation, and modulating gut microbiota","volume":"266","author":"Huang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"300ra128","DOI":"10.1126\/scitranslmed.aaa5657","article-title":"An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease","volume":"7","author":"Zhang","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.actbio.2024.07.054","article-title":"Matrix metalloproteinase-responsive hydrogels with tunable retention for on-demand therapy of inflammatory bowel disease","volume":"186","author":"Xie","year":"2024","journal-title":"Acta Biomater."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.actbio.2014.11.017","article-title":"Therapeutic efficacy of quercetin enzyme-responsive nanovesicles for the treatment of experimental colitis in rats","volume":"13","author":"Castangia","year":"2015","journal-title":"Acta Biomater."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ijbiomac.2017.08.071","article-title":"Enzyme sensitive smart inulin-dehydropeptide conjugate self-assembles into nanostructures useful for targeted delivery of ornidazole","volume":"106","author":"Shivhare","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.2147\/JIR.S450801","article-title":"Origin and Function of Monocytes in Inflammatory Bowel Disease","volume":"17","author":"Liao","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1124\/dmd.122.000898","article-title":"Gut Microbiome\u2013Wide Search for Bacterial Azoreductases Reveals Potentially Uncharacterized Azoreductases Encoded in the Human Gut Microbiome","volume":"51","author":"Braccia","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1021\/acs.biomac.5c01176","article-title":"Azo-Linked 5-ASA Hydrogel Microparticles with Enzyme Shielding for Sustained Drug Release in Ulcerative Colitis Therapy","volume":"26","author":"Jiang","year":"2025","journal-title":"Biomacromolecules"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1038\/s41598-019-41894-8","article-title":"Azoreductase activity of dye-decolorizing bacteria isolated from the human gut microbiota","volume":"9","author":"Zahran","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.nano.2015.02.018","article-title":"Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: Selective targeting to diseased versus healthy tissue","volume":"11","author":"Hua","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.drudis.2016.12.009","article-title":"Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy","volume":"22","author":"Wickens","year":"2017","journal-title":"Drug Discov. Today"},{"key":"ref_63","first-page":"981","article-title":"Hyaluronic acids protects against gastric infection","volume":"45","author":"Niu","year":"2018","journal-title":"Prog. Biochem. Biophys."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1093\/ibd\/izaa347.081","article-title":"Targeting Siderophores to Reduce Colonization of Adherent Invasive E. coli in Crohn\u2019s Disease","volume":"27","author":"Gerner","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"110952","DOI":"10.1016\/j.colsurfb.2020.110952","article-title":"Osteopontin-loaded PLGA nanoparticles enhance the intestinal mucosal barrier and alleviate inflammation via the NF-\u03baB signaling pathway","volume":"190","author":"Wei","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Lu, H., Xue, M., Nie, X., Luo, H., Tan, Z., Yang, X., Shi, H., Li, X., and Wang, T. (2023). Glycoside hydrolases in the biodegradation of lignocellulosic biomass. 3 Biotech, 13.","DOI":"10.1007\/s13205-023-03819-1"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/aem.44.6.1428-1434.1982","article-title":"Cellulolytic and non-cellulolytic bacteria in rat gastrointestinal tracts","volume":"44","author":"Macy","year":"1982","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00018-013-1388-z","article-title":"\u03b1-Amylase: An enzyme specificity found in various families of glycoside hydrolases","volume":"71","author":"Svensson","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1136\/gut.2006.093187","article-title":"Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21","volume":"55","author":"Monteleone","year":"2006","journal-title":"Gut"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2249.2008.03836.x","article-title":"Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium","volume":"155","author":"Pedersen","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2182117","DOI":"10.1080\/21688370.2023.2182117","article-title":"Matrix metalloproteinase-7 and claudin-7 as novel identified therapeutic targets for restoration of intestinal epithelial barrier in inflammatory bowel diseases","volume":"12","author":"Hankan","year":"2024","journal-title":"Tissue Barriers"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5606\/ArchRheumatol.2015.5064","article-title":"Association of Matrix Metalloproteinases and Their Tissue Inhibitor With Disease Activity and Development in Spondyloarthropathy and Inflammatory Bowel Disease","volume":"30","author":"Dursun","year":"2015","journal-title":"Arch. Rheumatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s10620-017-4568-0","article-title":"Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn\u2019s Disease","volume":"62","author":"Jonakowski","year":"2017","journal-title":"Dig. Dis. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1021\/acsami.1c21595","article-title":"Multistage-Responsive Nanocomplexes Attenuate Ulcerative Colitis by Improving the Accumulation and Distribution of Oral Nucleic Acid Drugs in the Colon","volume":"14","author":"Li","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_75","first-page":"007","article-title":"Polymeric Prodrugs: Recent Achievements and General Strategies","volume":"s15","author":"Agrawal","year":"2013","journal-title":"J. Antivir. Antiretrovir."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Tang, Z., Ma, Q., Chen, X., Chen, T., Ying, Y., Xi, X., Wang, L., Ma, C., Shaw, C., and Zhou, M. (2021). Recent Advances and Challenges in Nanodelivery Systems for Antimicrobial Peptides (AMPs). Antibiotics, 10.","DOI":"10.3390\/antibiotics10080990"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Ahmed, M.S., Yun, S., Kim, H.-Y., Ko, S., Islam, M., and Nam, K.-W. (2025). Hydrogels and Microgels: Driving Revolutionary Innovations in Targeted Drug Delivery, Strengthening Infection Management, and Advancing Tissue Repair and Regeneration. Gels, 11.","DOI":"10.3390\/gels11030179"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s12272-025-01569-7","article-title":"Curcumin for inflammatory bowel disease therapy: Advances in mechanisms, clinical applications, and drug delivery","volume":"48","author":"Zhang","year":"2025","journal-title":"Arch. Pharmacal Res."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Shurin, M.R., Kirichenko, V.A., Shurin, G.V., Lee, D., Crane, C., and Kirichenko, A.V. (2024). Radiomodulating Properties of Superparamagnetic Iron Oxide Nanoparticle (SPION) Agent Ferumoxytol on Human Monocytes: Implications for MRI-Guided Liver Radiotherapy. Cancers, 16.","DOI":"10.3390\/cancers16071318"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1186\/s13287-025-04792-7","article-title":"Therapeutic potential and mechanistic insights into adipose-derived stem cells and mesenchymal stem cell-derived exosomes in patients with Crohn\u2019s disease-associated fistulas: Challenges and future perspectives","volume":"16","author":"Sheykhhasan","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"121830","DOI":"10.1016\/j.lfs.2023.121830","article-title":"Extracellular vesicles and their indispensable roles in pathogenesis and treatment of inflammatory bowel disease: A comprehensive review","volume":"327","author":"Chen","year":"2023","journal-title":"Life Sci."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Goldi\u0219, A., Dragomir, R., Mercioni, M.A., Goldi\u0219, C., Sirca, D., Enatescu, I., and Belei, O. (2025). Introducing a Novel Personalized Microbiome-Based Treatment for Inflammatory Bowel Disease: Results from NostraBiome\u2019s Internal Validation Study. Biomedicines, 13.","DOI":"10.3390\/biomedicines13040795"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.chempr.2018.07.002","article-title":"Multi-Stimuli-Responsive Polymer Particles, Films, and Hydrogels for Drug Delivery","volume":"4","author":"Fu","year":"2018","journal-title":"Chem"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Parvin, N., Aslam, M., Alam, M.N., and Mandal, T.K. (2025). Nanotechnology Driven Innovations in Modern Pharmaceutics: Therapeutics, Imaging, and Regeneration. Nanomaterials, 15.","DOI":"10.3390\/nano15221733"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ecco-jcc\/jjaa143","article-title":"Gut microbiota-driven drug metabolism in inflammatory bowel disease","volume":"15","author":"Crouwel","year":"2021","journal-title":"J. Crohns Colitis"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2015.11.003","article-title":"Mucoadhesive vs. mucopenetrating particulate drug delivery","volume":"98","author":"Netsomboon","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["Polymers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4360\/18\/10\/1146\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T09:33:31Z","timestamp":1778146411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4360\/18\/10\/1146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":87,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["polym18101146"],"URL":"https:\/\/doi.org\/10.3390\/polym18101146","relation":{},"ISSN":["2073-4360"],"issn-type":[{"value":"2073-4360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]}}}